UM38-2 PGD Hypertrophic Cardiomyopathy Mutation

COMING SOON: UM38-2  Human Pluripotent Stem Cells   PGD; Hypertrophic Cardiomyopathy mutation

Catalog Number:  PLX03 001 R01

Cell number per vial:  1 million

High density RTD vials (>1 million/vial) are also available for custom applications, please contact Pluristyx for more information.

Product Summary

Pluristyx Ready-to-Differentiate (RTD™) cells are cryopreserved at 1 million cells per vial with a >80% viable cell recovery when handled and thawed following the instructions for use.

Format: Research Use Only; not for diagnostic or therapeutic purposes

Passage number:  pending

NIH Registration Number:  0155

NIH Approval Number: NIHhESC-12-0155

Karyotype:  pending

Pluripotency Markers:   OCT4 & SSEA-4 (>90%); SSEA-1 (<10%)

Cell Source

UM38-2 hPSC conform to Global Ethical Standards and Clinical Cell Regulations with complete donor history and testing information. The cells are registered with the National Institutes of Health (NIHhESC-12-0155).  Pluristyx is a licensed manufacturer and distributor of human pluripotent stem cells obtained the University of Michigan

Cell Bank Manufacturing

Pluristyx hPSC cell bank vials are tested and confirmed to be free of adventitious agents, including mycoplasma, bacteria, yeast, fungi, and human virus.  The cells have been characterized with regards to karyotype, pluripotency, and have been Short Tandem Repeat (STR) fingerprinted to confirm cell line identity.

These cells are for Research Use Only (RUO) and shall not be developed for diagnostic, therapeutic, or commercial use.